Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors.

Breast cancer research and treatment - 1 May 2003

Barlow John, Yandell David, Weaver Donald, Casey Theresa, Plaut Karen

Abstract excerpt

Transforming growth factor-beta (TGFB) is a potent inhibitor of normal epithelial cell proliferation, and may be one of the regulatory factors that are perturbed during tumor development. While many tumor cell lines no longer respond to the inhibitory effects of TGFB due to a reduction or absence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Epithelial Cells
Share to In Vitro Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymph Nodes

Share to Receptor, Transforming Growth Factor-beta Type II

Share to Receptors, Transforming Growth Factor beta

Share to Reference Values

Share to Stromal Cells

Source

Identifiers

PMID: 12825850
DOI: 10.1023/a:1023918026437

Genes

TGFBR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12825850-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors.PMID 12825850Read ↗

Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.Semantic proximity Read ↗

TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancerSemantic proximity Read ↗

Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis.Semantic proximity Read ↗

Association between the TGFBR2 G-875A polymorphism and cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

TGFBR1 signaling and breast cancer.Semantic proximity Read ↗

TGF-β signaling pathway and breast cancer susceptibility.Semantic proximity Read ↗

Identification of genetic alterations in the TGFbeta type II receptor gene promoter.Semantic proximity Read ↗

Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.Semantic proximity Read ↗

Role of TGF-beta in cancer and the potential for therapy and prevention.Semantic proximity Read ↗

TGFBR1*6A and breast tumor fibrosisSemantic proximity Read ↗

Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.Semantic proximity Read ↗

A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.